Skip to content

EBITDA margin at other companies

Baxter International logo
Baxter InternationalBAX
5.9%-6.2pp
Boston Scientific logo
Boston ScientificBSX
25.2%+1.6pp
ITG
Integer HoldingsITGR
18.3%-0.8pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
20.2%+0.9pp
Medtronic logo
MedtronicMDT
25.9%-0.4pp
Abbott logo
AbbottABT
24.1%-0.2pp

Other financials

Income statement

See full
Revenue$199.4M+25.7%
Gross profit$141.4M+29.4%
Operating income-$16.2M+50.3%
Net income-$13.9M+54.6%
EPS (diluted)-$0.43+55.7%

Balance sheet

See full
Cash & equivalents$248.5M-35.2%
Total debt$79.0M-10.5%
Total equity$161.2M+86.0%
Total assets$1.0B+8.7%

Cash flow

See full
Operating cash flow-$26.2M-232%
CapEx$6.9M-26.7%
Free cash flow-$33.1M-91.1%

Valuation

See full
Market cap$3.62B+16.0%

Profitability

See full
Gross margin71%+1.6pp
Operating margin-5.5%-2.2pp
Net margin-7.3%-3.1pp
FCF margin2.4%

Returns & leverage

See full
Return on equity-53.1%-17.4pp
Debt / equity0.5×-0.5×
Current ratio5.2×-0.5×

Where this comes from

Calculated from iRhythm Holdings, Inc. ’s reported figures.

Based on trailing twelve months.

The official record: iRhythm Holdings, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRhythm Holdings, Inc. 's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is iRhythm Holdings, Inc. 's EBITDA margin?
iRhythm Holdings, Inc. (IRTC) reported EBITDA margin of -2.9% in Q1 2026.
How has iRhythm Holdings, Inc. 's EBITDA margin changed year-over-year?
iRhythm Holdings, Inc. 's EBITDA margin increased by 80.0% year-over-year, from -14.4% to -2.9%.
What is the long-term trend for iRhythm Holdings, Inc. 's EBITDA margin?
Over 5 years (2020 to 2025), iRhythm Holdings, Inc. 's EBITDA margin has grown at a -17.8% compound annual growth rate (CAGR), from -13.9% to -5.2%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.